Back to Journals » Neuropsychiatric Disease and Treatment » Volume 17

MicroRNA-579-3p Exerts Neuroprotective Effects Against Ischemic Stroke via Anti-Inflammation and Anti-Apoptosis [Retraction]

Authors Jia J, Cui Y, Tan Z, Ma W, Jiang Y

Received 10 February 2021

Accepted for publication 10 February 2021

Published 12 February 2021 Volume 2021:17 Pages 481—482

DOI https://doi.org/10.2147/NDT.S306153


Jia J, Cui Y, Tan Z, Ma W, Jiang Y. Neuropsychiatr Dis Treat. 2020;16:1229–1238.

The Editor and Publisher of Neuropsychiatric Disease and Treatment wish to retract the published article.

The journal was notified by the Editor of Metabolic Brain Disease of a submission they received from another author group which had significant overlap with the paper published in Neuropsychiatric Disease and Treatment. The authors of the Neuropsychiatric Disease and Treatment paper could not be contacted for an explanation.

The Editor has determined the findings are no longer valid and has requested for the paper to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

 

Jia J, Cui Y, Tan Z, Ma W, Jiang Y. Neuropsychiatr Dis Treat. 2020;16:1229–1238.

The Editor and Publisher of Neuropsychiatric Disease and Treatment wish to retract the published article.

The journal was notified by the Editor of Metabolic Brain Disease of a submission they received from another author group which had significant overlap with the paper published in Neuropsychiatric Disease and Treatment. The authors of the Neuropsychiatric Disease and Treatment paper could not be contacted for an explanation.

The Editor has determined the findings are no longer valid and has requested for the paper to be retracted.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]